Harbor Capital Advisors Inc. Takes $981,000 Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Harbor Capital Advisors Inc. bought a new stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the 1st quarter, HoldingsChannel.com reports. The firm bought 1,547 shares of the biopharmaceutical company’s stock, valued at approximately $981,000. Several other hedge funds and other institutional investors have also made changes to their positions in REGN. Brighton Jones […]
